Long COVID affects 1 in 5 people following infection
Vaccination, masks and better indoor air are our best protections.
Many patients recover from COVID within a week or two, but at least one in five...
Is five days of COVID isolation enough?
When the Centers for Disease Control and Prevention (CDC) said in January it was shifting its recommended isolation period for people infected with COVID-19...
Where you live can affect your COVID death risk
Scientists from the University of Chicago used county-level data and found that different demographic groups are vulnerable to COVID-19 in different ways—often depending on...
This drug is effective in COVID-19 patients
Scientists from Spain confirmed that a drug protease inhibitor aprotinin prevented cells to be infected by the COVID-19 virus.
They found that patients receiving an...
Scientists find the cause of loss of smell in COVID-19
Scientists from Johns Hopkins Medicine found that inflammation caused by COVID-19, rather than the virus itself, may lead to loss of smell.
They found that...
Heart inflammation rare in people with severe COVID-19
Scientists from Niguarda Hospital found heart inflammation occurred in about two out of every 1,000 people hospitalized with COVID-19, and was linked to more...
Scientists predicts COVID-19 deaths will rebound when all restrictions are lifted
As COVID numbers fall and mandates lift, the question remains: Is it possible to avoid trade-offs between returning to pre-pandemic lifestyles and an uptick...
Current antiviral drug still can fight Omicron variant
Scientists from Rutgers found an antiviral drug used to treat SARS-CoV-2 remains effective against the newest variants of the evolving virus.
They found that the...
Vaccinated people get very mild breakthrough COVID infections
In a recent study published in Morbidity and Mortality Weekly Report, researchers found breakthrough COVID infections very mild for vaccinated people.
They found that vaccinated adults...
Many people report neuropathy pain after COVID-19
Scientists from Washington University found many people who got COVID-19 in the early months of the pandemic experienced peripheral neuropathy—pain, tingling, and numbness in...